Calavo Growers Appoints James Snyder as New CFO

Calavo Growers, Inc. (NASDAQ-GS: CVGW) has announced a change in its leadership with the appointment of James Snyder as the new Chief Financial Officer effective December 2, 2024. This comes as Shawn Munsell, the current CFO, departs the company on November 29 to pursue a new opportunity.

Snyder, who previously served as the company’s corporate controller and chief accounting officer for over 18 years, expressed eagerness to return to Calavo in his new role. His extensive experience within the company is expected to facilitate a smooth transition and continuity in financial leadership.

Notably, Snyder most recently held the position of corporate controller and chief accounting officer at Gem-Pack Berries in Irvine, California. Prior to that, he served in a similar capacity for Nano Banc of Irvine from 2020 to 2024. His career also includes seven years in various audit functions at Deloitte.

This change in leadership comes as Calavo Growers, Inc. continues to solidify its position as a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole. The company's products are sold under its trusted Calavo brand name, as well as proprietary sub-brands, private label, and store brands.

With a rich culture of innovation, sustainable practices, and market growth, Calavo serves various sectors including retail grocery, foodservice, club stores, mass merchandisers, food distributors, and wholesalers worldwide. The company is headquartered in Santa Paula, California, and operates facilities throughout the U.S. and Mexico.

The departure of Shawn Munsell and the appointment of James Snyder are significant changes in the company's financial leadership, marking a shift in the executive team. It will be interesting to see how these changes impact Calavo's financial strategies and performance in the upcoming quarters. Today the company's shares have moved 0.1% to a price of $27.17. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS